Suspensions of oxfendazole, methyl [5-(Phenylsulfinyl)-1H-benzimidazol
e-2-yl] carbamate, a broad spectrum anthelmintic of the benzimidazole
class of compounds, were administered to normal young beef cattle (est
imated age 5-9 months) typical of those entering anthelmintic programs
in feedlots. The purposes of the studies were to characterize the acu
te toxicity profile and to demonstrate the safety of oxfendazole in th
is class of cattle. Suspensions of oxfendazole were also administered
to cycling first calf beef heifers and to normal, sexually mature beef
bulls to demonstrate the safety of oxfendazole in cattle of breeding
age. The studies reported herein comprised the target animal safety pr
ogram for registration of oxfendazole in cattle in the United States.
The intended clinical dose of oxfendazole for cattle is 4.5 mg/kg.